| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/23/1996 | CA2021714C Liver function improver |
| 07/18/1996 | WO1996021656A1 Estrogen agonists/antagonists |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021641A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996021443A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
| 07/18/1996 | WO1996021439A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
| 07/18/1996 | WO1996001253A3 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209936A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | CA2208859A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment |
| 07/17/1996 | EP0721955A2 Diadenosine tetraphosphate tetrasodium salt dodecahydrate crystals |
| 07/17/1996 | EP0721947A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/1996 | EP0721938A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/1996 | EP0721742A1 Nutrition for elderly patients |
| 07/17/1996 | EP0721500A1 Insulin-secreting cell lines, methods of production and use |
| 07/17/1996 | EP0721462A1 4-azasteroids with side-chain fluoroketones |
| 07/17/1996 | EP0721460A1 3-carboxysteroids with a fluorinated side chain |
| 07/17/1996 | CN1126727A 11,21-bisphenyl-19-norpregnane derivatives |
| 07/17/1996 | CN1032309C 吲哚衍生物 Indole derivatives |
| 07/16/1996 | US5536713 Osteoporosis |
| 07/16/1996 | US5536500 Monoesters and diesters of cinnamic acid or of one of the derivatives thereof and of vitamin c, process for the preparation thereof, and use as antioxidants in cosmetic, pharmaceutical or nutritional compositions |
| 07/16/1996 | US5536469 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system |
| 07/11/1996 | WO1996021037A1 Arachidonic acid and methods for the production and use thereof |
| 07/11/1996 | WO1996020930A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/11/1996 | WO1996020913A1 Novel trienoic retinoid compounds and methods |
| 07/11/1996 | WO1996020724A1 Generation of human insulin |
| 07/11/1996 | WO1996020708A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 07/11/1996 | CA2208844A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity |
| 07/10/1996 | EP0720855A2 Composition for the treatment of hypertension comprising non halide salts of potassium |
| 07/10/1996 | EP0720601A1 Gastrin and cck receptor ligands |
| 07/10/1996 | EP0720599A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 07/10/1996 | EP0720597A1 Triaryl-ethylene derivatives for use in therapy |
| 07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
| 07/10/1996 | EP0720481A1 Uses of vegetable oils |
| 07/10/1996 | CN1126434A Therapeutic substituted guanidines |
| 07/10/1996 | CN1126207A Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
| 07/10/1996 | CN1126198A Substituted cyclohexanolester, disease treatment application and pharmaceutical agent of same |
| 07/09/1996 | US5534551 Production of powder which can be compressed into a tablet |
| 07/09/1996 | US5534530 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them |
| 07/09/1996 | US5534529 Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 07/09/1996 | US5534503 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses |
| 07/09/1996 | US5534488 Combining zinc with insulin and proteins |
| 07/04/1996 | WO1996020279A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020184A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | WO1996020005A1 Protracted glp-1 compositions |
| 07/04/1996 | WO1996020004A1 Therapeutic agent for disorder of lipid metabolism |
| 07/04/1996 | WO1996019998A1 Bone mass anabolic composition comprising olpadronate |
| 07/04/1996 | WO1996019991A1 Benzimidazoles as inhibitors of calcitriol metabolism |
| 07/04/1996 | CA2208502A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2207772A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | CA2184248A1 Therapeutic agent for disorder of lipid metabolism |
| 07/03/1996 | EP0719783A2 Phosphorylated saccharide and method for producing the same |
| 07/03/1996 | EP0719767A1 Succinamic acid compound, process for producing the same, and use thereof |
| 07/03/1996 | EP0719558A1 Ranolazine and related piperazines for use in the treatment of shock conditions |
| 07/03/1996 | EP0719148A1 Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt |
| 07/03/1996 | EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders |
| 07/03/1996 | EP0719143A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 07/03/1996 | EP0719140A1 Use of thiazolidinediones to prevent or delay onset of niddm |
| 07/03/1996 | EP0597107B1 Lignan analog, production thereof, and hypolipidemic drug |
| 07/03/1996 | CN1125941A Novel vitamin D analogues |
| 07/03/1996 | CN1032210C Process for preparing substituted thienopyrans as antihypertensive agents |
| 07/03/1996 | CN1032206C Process for preparing tetrahydrofolic acid |
| 07/03/1996 | CN1032203C Process for preparing substituled 2-pyridones and pyrid-2-thiones |
| 07/02/1996 | US5532387 Cyclization of trimethylhydroquinone and an alkenyl alcohol, reusable catalyst, iiib fluorosulfonate, nitrate, sulfate, or fluoroalkylsulfonate |
| 07/02/1996 | US5532269 Administering thioctic acid or derivatives; vasodilation; side effect reduction |
| 07/02/1996 | US5532257 Benzothiazole compound, production thereof and use thereof |
| 07/02/1996 | US5532242 Central nervous system cognition activators, anxiety and antidepressants |
| 07/02/1996 | US5532233 Platelet activating factor antagonist |
| 07/02/1996 | US5532227 Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive glycosylation of different types of collagen and other proteins during diabetes |
| 07/02/1996 | US5532226 Trifluoromethybenzylphosphonates useful in treating osteoporosis |
| 07/02/1996 | US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates |
| 06/27/1996 | WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 06/27/1996 | WO1996019451A1 Substituted azetidin-2-ones for treatment of atherosclerosis |
| 06/27/1996 | WO1996019450A1 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| 06/27/1996 | WO1996019246A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 06/27/1996 | WO1996019236A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 06/27/1996 | CA2208530A1 Substituted azetidin-2-ones for treatment of atherosclerosis |
| 06/27/1996 | CA2205959A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 06/26/1996 | EP0718308A2 Peptide derivatives having binding activity to modified low density lipoprotein |
| 06/26/1996 | EP0718295A1 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis |
| 06/26/1996 | EP0718285A2 Restricted 9-cis-retinoids |
| 06/26/1996 | EP0718281A1 Cyclohexanediurea derivative and process for producing the same |
| 06/26/1996 | EP0717751A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t |
| 06/26/1996 | EP0717746A1 Phosphinic acid derivatives with anti-hyper glycemic and/or anti-obesity activity |
| 06/26/1996 | EP0717635A1 Methods for regulating gastrointestinal motility |
| 06/26/1996 | EP0717625A1 A method of treating liver disease and like indications with vasodilating agents |
| 06/26/1996 | EP0717623A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
| 06/26/1996 | CN1125192A Apparatus and method for administering minerals |
| 06/26/1996 | CN1125134A Traditional Chinese medicine for reducing blood-lipid and its preparing technology |
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/25/1996 | US5530020 Taxol derivatives |
| 06/25/1996 | US5530009 Treating asthma |
| 06/25/1996 | US5529991 Oral 1α-hydroxyprevitamin D |
| 06/25/1996 | CA1338419C Substituted thienopyrans as antihypertensive agents |
| 06/25/1996 | CA1338417C Benzothiazepine derivatives |
| 06/20/1996 | WO1996018737A2 Vectors and viruses for use in gene therapy |
| 06/20/1996 | WO1996018725A1 Human tissue inhibitor of metalloproteinase-4 |